Welcome!

News Feed Item

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

LONDON, Jan. 22, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

Summary

Uveitis is a serious eye condition that often results in permanent vision damage due to frequent recurrence even after treatment. It consists of a group of diseases that present with inflammation of the uvea, can occur in one or both eyes, and may also affect the adjacent tissues such as the retina, optic nerve, and vitreous humor. Symptoms may include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye, and sensitivity to light. Uveitis has a wide variety of causes such as autoimmune disorders, infectious agents, or toxins; however, the cause is often unknown for a significant proportion of the cases.

In 2012, GlobalData epidemiologists forecast the 6MM had 223,559 incident cases of uveitis, 75% of which (168,264 cases) occurred in the US. Incident cases in the 6MM are expected to increase slightly to 245,353 cases by 2022, at the rate of 0.97% per year. In 2012, the 6MM had 665,778 prevalent cases of uveitis, which will increase to 730,913 cases in 2022 at the rate of 0.98% per year. The US also had the largest proportion of prevalent cases in 2012 (53.69%, 357,483 cases) out of all markets covered in this analysis. The forecast further shows anterior uveitis is the most common form of uveitis and non-infectious uveitis is the most common etiology among the 6MM.

This forecast provides detailed, granular, and clinically relevant segmentations of uveitis cases. The segmentations will allow for improved understanding of the disease and the ability to focus on specific subgroups within the disease. The analysis is further strengthened by the adherence to the standard clinical reporting guidelines from the International Uveitis Study Group (IUSG) and Standardization of Uveitis Nomenclature (SUN) Working Group. Using standard guidelines across the 6MM allows for meaningful comparisons across the markets and ensures these results will be relevant in reference to future studies, as the use of the guidelines are becoming more common in epidemiological research.

Scope

- This report provides an overview of the risk factors, comorbidities and the global epidemiological trends for uveitis in the six major markets (6MM: US, France, Germany, Italy, Spain, and UK). The report also includes a 10-year forecast of incident and prevalent cases of uveitis segmented by age, sex, primary anatomical location of inflammation (anterior, intermediate, posterior, panuveitis), and by etiology (infectious, non-infectious, idiopathic). Incident cases are further segmented by course of disease (acute, recurrent, chronic) and by severity (mild, moderate, severe).
- The uveitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global uveitis market.
- Quantify patient populations in the global uveitis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the patient segmentations that present the best opportunities for uveitis therapeutics in each of the markets covered.
- Identify the number of uveitis cases in each anatomical location category and in each etiology.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.2.1 Smoking increases risk of uveitis and increases complications 11
3.2.2 Juvenile idiopathic arthritis patients need regular ophthalmologic screenings 12
3.2.3 HLA-positive antigens are linked to certain types of uveitis 13
3.2.4 Uveitis is associated with various autoimmune, neurological, and infectious diseases 13
3.3 Global Trends 15
3.3.1 US 17
3.3.2 5EU 20
3.4 Forecast Methodology 22
3.4.1 Sources Used 25
3.4.2 Sources Not Used 30
3.4.3 Forecast Assumptions and Methods, Incident Cases 31
3.4.4 Forecast Assumptions and Methods, Prevalent Cases 32
3.4.5 Forecast Assumptions and Methods, Etiological and Anatomical Distribution 33
3.4.6 Forecast Assumptions and Methods, Course of Disease 36
3.4.7 Forecast Assumptions and Methods, Disease Severity 37
3.5 Epidemiological Forecast of Uveitis (2012-2022) 37
3.5.1 Incident Cases of Uveitis 37
3.5.2 Age-Specific Incident Cases of Uveitis 39
3.5.3 Sex-Specific Incident Cases 41
3.5.4 Age-Standardized Incidence Rates 42
3.5.5 Incident Cases by Anatomical Location 43
3.5.6 Incident Cases Segmented by Etiology 45
3.5.7 Course of Disease of Incident Uveitis Cases 48
3.5.8 Severity of Incident Uveitis Cases 50
3.5.9 Prevalent Cases of Uveitis 51
3.5.10 Age-Specific Prevalent Cases of Uveitis 53
3.5.11 Sex-Specific Prevalent Cases of Uveitis 54
3.5.12 Prevalent Cases by Anatomical Location 56
3.5.13 Prevalent Cases by Etiology 57
3.6 Discussion 59
3.6.1 Epidemiological Forecast Insight 59
3.6.2 Limitations of the Analysis 59
3.6.3 Strengths of the Analysis 61
4 Appendix 62
4.1 Bibliography 62
4.2 About the Authors 67
4.2.1 Epidemiologists 67
4.2.2 Reviewers 67
4.2.3 Global Director of Epidemiology and Health Policy 69
4.2.4 Global Head of Healthcare 69
4.3 About GlobalData 70
4.4 About EpiCast 70
4.5 Disclaimer 71

List of Tables

Table 1: Diseases Most Frequently Associated with Uveitis 14
Table 2: Distribution of Uveitis by Anatomical Location in Community and Referral Centers 20
Table 3: Distribution of Uveitis Cases by Anatomical Location of Inflammation, Europe 22
Table 4: IUSG/SUN Working Group Classification of Uveitis by Anatomical Location 23
Table 5: Clinical Classifications of Uveitis 23
Table 6: 6MM, Sources of Incidence and Prevalence of Uveitis in the 6MM 24
Table 7: Italy, Anatomy Classification Calculation 34
Table 8: US, Anatomical Locations of Uveitis for Incident and Prevalent Cases 36
Table 9: 6MM, Incident Cases of Uveitis, N (Column %), Select Years 2012-2022 38
Table 10: 6MM, Age-Specific Incident Cases of Uveitis, N (Row %), 2012 39
Table 11: 6MM, Sex-Specific Incident Cases of Uveitis, N (Row %), 2012 41
Table 12: 6MM, Incident Cases of Uveitis by Primary Anatomical Location of Inflammation, N (Row %), 2012 44
Table 13: 6MM, Incident Cases of Uveitis Segmented by Etiology and Age, N (Column %), 2012 46
Table 14: 6MM, Incident Cases of Uveitis Segmented by Etiology and Anatomical Location, N, 2012 47
Table 15: 6MM, Incident Cases of Uveitis by Course of Disease, N (Row %), 2012 48
Table 16: 6MM, Incident Cases of Uveitis by Severity of Disease, N, 2012 50
Table 17: 6MM, Prevalent Cases of Uveitis, N (Column %), Select Years, 2012-2022 52
Table 18: 6MM, Age-Specific Prevalent Cases of Uveitis, N (Row %), 2012 53
Table 19: 6MM, Sex-Specific Prevalent Cases of Uveitis, N (Row %), 2012 55
Table 20: 6MM, Prevalent Cases of Uveitis by Anatomical Location of Inflammation, N (Row %), 2012 56
Table 21: 6MM, Prevalent Cases of Uveitis Segmented by Etiology and Age, N (Column %), 2012 57
Table 22: 6MM, Prevalent Cases of Uveitis Segmented by Etiology and Anatomical Location, 2012 58

List of Figures

Figure 1: US, Age Distribution of Study Populations Compared with the US General Population 18
Figure 2: US, Sex-Ratio of Study Populations Compared with the US General Population 19
Figure 3: 6MM, Incident Cases of Uveitis, N, 2012-2022 38
Figure 4: 6MM, Age-Specific Incident Cases of Uveitis, N, 2012 40
Figure 5: 6MM, Sex-Specific Incident Cases of Uveitis, N, 2012 42
Figure 6: 6MM, Age-Standardized Uveitis Incidence, Cases per 100,000 Population, Men and Women, 2012 43
Figure 7: 6MM, Incident Cases of Uveitis by Primary Anatomical Location of Inflammation, N, 2012 45
Figure 8: 6MM, Incident Cases of Uveitis by Course of Disease, N, 2012 49
Figure 9: 6MM, Incident Cases of Uveitis by Severity of Disease, N, 2012 51
Figure 10: 6MM, Prevalent Cases of Uveitis, N, 2012-2022 52
Figure 11: 6MM, Age-Specific Prevalent Cases of Uveitis, N, 2012 54
Figure 12: 6MM, Sex-Specific Prevalent Cases of Uveitis, N, 2012 55

Read the full report:
EpiCast Report: Uveitis - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/healthcare/epicast_report_uveitis_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smar...
Unsecured IoT devices were used to launch crippling DDOS attacks in October 2016, targeting services such as Twitter, Spotify, and GitHub. Subsequent testimony to Congress about potential attacks on office buildings, schools, and hospitals raised the possibility for the IoT to harm and even kill people. What should be done? Does the government need to intervene? This panel at @ThingExpo New York brings together leading IoT and security experts to discuss this very serious topic.
Internet of @ThingsExpo has announced today that Chris Matthieu has been named tech chair of Internet of @ThingsExpo 2017 New York The 7th Internet of @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, New York. Chris Matthieu is the co-founder and CTO of Octoblu, a revolutionary real-time IoT platform recently acquired by Citrix. Octoblu connects things, systems, people and clouds to a global mesh network allowing users to automate and control design flo...
"We analyze the video streaming experience. We are gathering the user behavior in real time from the user devices and we analyze how users experience the video streaming," explained Eric Kim, Founder and CEO at Streamlyzer, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events has announced today that Roger Strukhoff has been named conference chair of Cloud Expo and @ThingsExpo 2017 New York. The 20th Cloud Expo and 7th @ThingsExpo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "The Internet of Things brings trillions of dollars of opportunity to developers and enterprise IT, no matter how you measure it," stated Roger Strukhoff. "More importantly, it leverages the power of devices and the Internet to enable us all to im...
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
Information technology is an industry that has always experienced change, and the dramatic change sweeping across the industry today could not be truthfully described as the first time we've seen such widespread change impacting customer investments. However, the rate of the change, and the potential outcomes from today's digital transformation has the distinct potential to separate the industry into two camps: Organizations that see the change coming, embrace it, and successful leverage it; and...
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
Bert Loomis was a visionary. This general session will highlight how Bert Loomis and people like him inspire us to build great things with small inventions. In their general session at 19th Cloud Expo, Harold Hannon, Architect at IBM Bluemix, and Michael O'Neill, Strategic Business Development at Nvidia, discussed the accelerating pace of AI development and how IBM Cloud and NVIDIA are partnering to bring AI capabilities to "every day," on-demand. They also reviewed two "free infrastructure" pr...
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
Get deep visibility into the performance of your databases and expert advice for performance optimization and tuning. You can't get application performance without database performance. Give everyone on the team a comprehensive view of how every aspect of the system affects performance across SQL database operations, host server and OS, virtualization resources and storage I/O. Quickly find bottlenecks and troubleshoot complex problems.